Kalaris Therapeutics (NASDAQ:KLRS) CAO Sells 1,915 Shares
Kalaris Therapeutics Inc. (NASDAQ:KLRS - Get Free Report) CAO Brett Hagen sold 1,915 shares of Kalaris Therapeutics stock in a transaction dated Friday, March 20th. The stock was sold at an average price of $6.72, for a total transaction of $12,868.80. The transaction was disclosed in a legal...